Bausch Health Companies Inc. (BHC) Stock

Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals International, Inc., is a global leader in the pharmaceutical and healthcare industries. The company, headquartered in Laval, Canada, operates through five distinct segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products.

Bausch + Lomb, a cornerstone of the company, focuses on vision care, surgical, and ophthalmic pharmaceutical products, catering to global markets. The Salix segment specializes in gastroenterology treatments within the United States, while the International Rx segment extends its reach across Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East with a diverse portfolio that includes Solta medical devices and a variety of pharmaceutical products.

Additionally, the Ortho Dermatologics segment provides dermatological solutions in the U.S. and medical aesthetic devices internationally. The Diversified Products segment rounds out the company's offerings with pharmaceuticals in neurology and other therapeutic areas, alongside generics and dental products in the United States. Bausch Health Companies Inc. continues to innovate and expand its footprint in critical therapeutic areas like eye health, gastroenterology, and dermatology, reinforcing its commitment to enhancing global healthcare.